Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
AMGEN INC (AMGN)
Sector: Healthcare; Industry: Drug Manufacturers—General

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. It also markets other products in various markets, including Nplate, Vectibix, Repatha, Parsabiv, BLINCYTO, Aimovig, NEUPOGEN, Otezla, AMGEVITA, KANJINTI, EVENITY, IMLYGIC, MVASI, and Corlanor. The company has collaboration agreements with Novartis; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; QIAGEN N.V.; and Adaptive Biotechnologies.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-05-12 SUGAR RONALD D Director Sell 1,000 $250.59 $250,590 Yes
2021-04-14 SUGAR RONALD D Director Sell 1,000 $249.98 $249,980 Yes
2021-03-10 SUGAR RONALD D Director Sell 1,000 $231.53 $231,530 Yes
2021-02-10 SUGAR RONALD D Director Sell 1,000 $238.40 $238,400 Yes
2021-01-13 SUGAR RONALD D Director Sell 1,000 $235.99 $235,990 Yes
2020-08-19 SUGAR RONALD D Director Sell 1,000 $241.02 $241,020 Yes
2020-07-22 SUGAR RONALD D Director Sell 1,000 $259.79 $259,790 Yes
2020-06-17 SUGAR RONALD D Director Sell 1,000 $228.54 $228,540 Yes
2020-05-20 SUGAR RONALD D Director Sell 1,000 $229.27 $229,270 Yes
2020-04-22 SUGAR RONALD D Director Sell 1,000 $233.35 $233,350 Yes
2019-11-06 SUGAR RONALD D Director Sell 2,000 $215.45 $430,900 Yes
2019-10-02 SUGAR RONALD D Director Sell 2,000 $193.58 $387,160 Yes
2019-09-04 SUGAR RONALD D Director Sell 2,000 $206.70 $413,400 Yes
2019-08-07 SUGAR RONALD D Director Sell 2,000 $183.04 $366,080 Yes
2019-07-03 SUGAR RONALD D Director Sell 2,000 $187.58 $375,160 Yes
2019-06-05 SUGAR RONALD D Director Sell 2,000 $175.68 $351,360 Yes
2019-05-01 SUGAR RONALD D Director Sell 2,000 $175.73 $351,460 Yes
2019-04-03 SUGAR RONALD D Director Sell 2,000 $193.18 $386,360 Yes
2019-03-06 SUGAR RONALD D Director Sell 2,000 $188.88 $377,760 Yes
2019-02-07 SUGAR RONALD D Director Sell 2,000 $190.00 $380,000 Yes

Insider Smart

Celldex Therapeutics, Inc. (CLDX) - Multiple insiders including President, EVP, CEO, CSO and Directors bought shares on Jun.9th, first time since 2018, this was very convincing and we initiated a position. Stock soared from $3 to 9$ in 2 days, and the run is still going on.

Insider Smart

CARNIVAL CORP (CCL) - Cruislines $CCL $NCLH $RCL took a huge beat due to the pandemic, concerns of bankruptcy were raised. Among the three dominating companies in the industry, $CCL is the first one bought by insiders, such a bold move would definitely boost investor confidence.